Get started
Author

Alison M. Morilla

Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b)
1997 · Elisabeth J. Moreau, Estella Matutes, et al. · American Journal of Clinical Pathology · 402
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
2004 · Ilaria Del Giudice, Estella Matutes, et al. · PubMed · 126
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
2010 · D. Oscier, R. Wade, et al. · Haematologica · 121
PDF
Evaluation of ZAP‐70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process
2006 · Remi Letestu, Andy Rawstron, et al. · Cytometry Part B Clinical Cytometry · 82
PDF
Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML
2014 · C Anthias, F L Dignan, et al. · Bone Marrow Transplantation · 80
ζ‐Chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia
2005 · Ilaria Del Giudice, Alison Morilla, et al. · Cancer · 72
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma
2012 · Sarah L. Hockley, Monica Else, et al. · British Journal of Haematology · 71
Detection of minimal residual disease in B‐lineage acute lymphoblastic leukaemia by quantitative flow cytometry
1998 · Nahla Farahat, Alison Morilla, et al. · British Journal of Haematology · 68
Diagnostic Significance of CD20 and FMC7 Expression in B-Cell Disorders
2003 · Julio Delgado, Estella Matutes, et al. · American Journal of Clinical Pathology · 63
IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)
2006 · I Del Giudice, Z Davis, et al. · Leukemia · 57
Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL
2008 · Alison Morilla, David Gonzalez de Castro, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 54
Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns
2009 · Sarah L. Hockley, Stavroula Giannouli, et al. · British Journal of Haematology · 53
High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia
2011 · S L Hockley, G J Morgan, et al. · Leukemia · 48
CD52 expression in T-cell large granular lymphocyte leukemia – Implications for treatment with alemtuzumab
2005 · N Osuji, I Del Giudice, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Prognostic Factors in the UK LRF CLL4 Trial.
2006 · David Graham Oscier, Rachel Wade, et al. · Blood · 29
Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS)
2016 · N. Mehra, G. Seed, et al. · Annals of Oncology · 13
PDF
Prognostic Factors in the UK LRF CLL4 Trial.
2005 · David Graham Oscier, Sue Richards, et al. · Blood · 13
The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023–2024)
2024 · Bethany Torr, Nicola Bell, et al. · Journal of Medical Genetics · 8
PDF
Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma
2010 · S L Hockley, A Morilla, et al. · Leukemia · 8
Prolonged treatment response in aggressive natural killer cell leukemia
2005 · N Osuji, E Matutes, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Inter‐laboratory validation of a harmonized PNH flow cytometry assay
2018 · Daniel Payne, Ulrika Johansson, et al. · Cytometry Part B Clinical Cytometry · 6
PDF
Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.
2004 · Daniel Catovsky, Estella Matutes, et al. · Blood · 6
Immunophenotyping by Flow Cytometry
2017 · Ricardo Morilla, Alison M. Morilla, et al. · Elsevier eBooks · 5
The use of unfixed bone marrow trephines for multicolour flow cytometry
2017 · R. Morilla, K. Moss, et al. · Methods · 3
High neutrophil-to-lymphocyte ratio (NLR), myeloid-derived suppressor cells (MDSCs) and resistance to corticosteroid therapy (CST) in castration-resistant prostate cancer (CRPC).
2016 · Niven Mehra, Ricardo Marcelo Morilla, et al. · Journal of Clinical Oncology · 3
Works count: 42
Citation count: 1,443
H-index: 15
I10-index: 17
Year
Topic
Type